Highbridge Capital Management LLC Bio Line Rx Ltd. Transaction History
Highbridge Capital Management LLC
- $435 Million
- Q4 2024
A detailed history of Highbridge Capital Management LLC transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Highbridge Capital Management LLC holds 1,010,012 shares of BLRX stock, worth $3.49 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,010,012Holding current value
$3.49 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding BLRX
# of Institutions
39Shares Held
4.24MCall Options Held
46.5KPut Options Held
6.3K-
Alyeska Investment Group, L.P. Chicago, IL866KShares$3 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE816KShares$2.82 Million4.05% of portfolio
-
Morgan Stanley New York, NY198KShares$683,4780.0% of portfolio
-
Values First Advisors, Inc.166KShares$575,9130.02% of portfolio
-
Pvg Asset Management Corp Golden, CO157KShares$543,9630.37% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $213M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...